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ABSTRACT: We wanted to determine the procoagulant activity (PCA) of bron-
choalveolar lavage fluids, in order to understand the macrophage-mediated lung
injury at the site of tuberculous lesion.
Alveolar lavage fluids taken from the site of a lesion (radiologically abnormal site
(RAS)) and an unaffected site (radiologically normal site (RNS)) of active pulmonary
tuberculosis (TB) patients (n=7) and inactive (cured) patients (n=9) were studied
for their PCA producing potential. The observed results were not significant using
Mann-Whitney test, and thus all increases/decreasesreported below are trends/
tendencies only.
An increased PCA was seen in 4 out of 7 cell-free lavage supernatants of active-
TB taken from the site of lesion (RAS), compared to only 1 out of 9 in inactive-
TB. The PCA producing potential of the alveolar macrophages of RAS and RNS
of active-TB patients was enhanced when the alveolar macrophages were co-
cultured with autologous peripheral blood lymphocytes under in vitro condition.
Stimulation with purified protein derivative (PPD) of M. tuberculosis showed a vari-
able (increased or decreased) PCA production. Peripheral blood monocytes and
total mononuclear cells (monocytes+ lymphocytes) of active-TB patients stimu-
lated with or without PPD showed increased PCA production, compared with nor-
mal individuals and inactive-TB patients.
The present study suggests that increased production of PCA by the alveolar
macrophages, in collaboration with lymphocytes and other cells at the site of tuber-
culous lesions will result in fibrin formation. The deposition of fibrin in the alve-
oli may lead to further lung injury.
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Lung parenchymal injury is one of the basic mechan-
isms involved in the pathogenesis of granulomatous
lung diseases. The mechanism of macrophage-mediated
tissue injury in the pathogenesis of the granulomatous
lung diseases has been extensively reviewed [1]. A
complex relationship has been observed between the
macrophage and the coagulation-fibrinolytic pathways.
Activation of the coagulation system and fibrin depo-
sition has been associated with delayed type hypersensi-
tivity and granulomatous inflammatory reactions. [1, 2].
Fibrin deposition in the alveolar space and in the inter-
stitial tissue is a conspicuous feature of many types of
inflammatory reactions [3-5]. Pathways of inflammation
and coagulation are closely interrelated at the humoral
and cellular levels [6]. Mononuclear phagocytes of var-
ious types have been found to display procoagulant acti-
vities (PCA), of which thromboplastin (tissue factor) has
been shown to be one of the factors which is involved in
the formation of fibrin [7]. Other inflammatory cells,
such as neutrophils and lymphocytes, do not express PCA
[8-11]. However, tissue factor has also been detected in
human fibroblasts [12], smooth muscle cells [13], and
endothelial cells [14] under i  vitro conditions. It has
been shown that a variety of stimuli induce the synthe-
sis of PCA in monocytes and macrophages [8, 10, 11,
15
Pulmonary tuberculosis is a granulomatous disease of
the lung caused by M. tuberculosis. Altered levels of
alve lar macrophages and other inflammatory cells,
such as lymphocytes, have been found in the bron-
choalveolar lavage (BAL) fluids of tuberculosis patients
[16-18].
The present study was carried out to understand the
immunopathological changes occurring at the site of
t berculous lesions.PCA production by the activated
mac ophage has been recognized to be an in vitro mea-
sure of cell-mediated immunity. The production of PCA
as  tissue factor by monocytes and macrophages, and
the release of this factor as a consequence of macro-
phage and lymphocyte interactions that are involved
in the pathogenesis of pulmonary tuberculosis has been
s u ied.
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Materials and methods
Subjects
Fibreoptic bronchoscopy and BAL were performed on
7 active pulmonary tuberculosis patients (6 nonsmokers
and 1 smoker), and 9 inactive pulmonary tuberculosis
patients (6 nonsmokers and 3 smokers).
Active tuberculosis patients (ATE). Patients attending
the Tuberculosis Research Centre, Madras, with respira-
tory symptoms and radiographic abnormalities sugges-
tive of pulmonary tuberculosis were evaluated for the
study. At the time of initial assessment, all patients had
six sputum smears negative for acid-fast bacilli (APB).
These patients had respiratory symptoms of less than
6 months duration and all had minimal radiographic
abnormalities in one of the upper zones. None had rec-
eived any antituberculosis treatment in the past. Among
these patients, there were 7 patients whose sputa or lav-
age fluids had shown growth of Mycobacterium tuber-
culosis and they were classified as active pulmonary
tuberculosis patients.
Inactive tuberculosis (cured) patients (ITB). Patients
classified as suffering from active pulmonary tuberculo-
sis (by BAL technique) were given antituberculosis treat-
ment at our centre. All these patients (n=9) had received
a short course chemotherapy of 6-8 months duration.
BAL was repeated in these patients after chemotherapy.
These patients had sputum smears negative for AFB at
the time of evaluation. Sputa and lavage cultures were
also negative for M. tuberculosis.
Fibreoptic bronchoscopy and bronchoalveolar lavage
All subjects in the present study were subjected to
fibreoptic bronchoscopy and BAL. The procedure for
fibreoptic bronchoscopy and BAL has been described
previously [19, 20], and was performed at the site of
lesion of the affected lobe (radiologically abnormal
site (RAS)) and at an unaffected site (radiologically nor-
mal site (RNS)) from the unaffected lobe. The alveolar
lavage fluids of the active and inactive pulmonary
tuberculosis (cured) patients were centrifuged at 300xg
for 10 min. The cell-free supernatants and the alveolar
cells were used separately for PCA assay.
Peripheral blood mononuclear cells
Peripheral blood samples drawn from the active and
inactive pulmonary tuberculosis patients who under-
went BAL and from normal laboratory volunteers were
used. Mononuclear cells were separated using Ficoll-
Hypaque, as described by BOYUM.[21]. The cells were
washed three times in RPMI-1640 tissue culture medi-
um, with 2 mM L-glutamine (Flow Laboratories, Irvine,
Scotland, UK) containing 10% foetal bovine serum
(PBS) (Intergen Purchase, NY, USA) and gentamicin
50 µg.ml-1 (M.A. Bioproducts, Walkersville, Maryland,
USA) and fungizone 2.5 µg.ml-1 (Squibb, Princefon,
NJ, USA). The cells were adjusted to 5x106 cells.ml-1
culture medium.
Differential count
Smears of alveolar cells from the patients were stained
with Diff-Quick (Halerco, Gibbstown, NJ, USA). A
total of 300 cells was counted for each smear [17].
Nonspecific esterase staining
Smears of peripheral blood mononuclear cells were
stained for nonspecific esterase for determination of
the percentage of monocytes, according to the method
of HORWITZ et al. [22]. A total of 300 cells was coun-
ted, and the percentage monocytes (esterase positive
cells) among them was determined.
Design of the experiment
Five hundred microlitres of 1x106 cells.ml-1 concen-
tration of alveolar macrophages, or 5x106 cells.ml-1
blood mononuclear cells were seeded in 24-well pla-
tes (Costar, Cambridge, MA, USA). The nonadherent
c ll population, mainly lymphocytes, was removed
from he wells seeded with blood mononuclear cells
by aspiration after one hour incubation at 37°C. Alveo-
lar macrophages were used as such. The adherent mono-
nuclear cells (monocytes - nonspecific esterase positive
cells) and the alveolar macrophages were cultured for
72 h at 37°C either with or without purified protein
derivative (PPD) of M. tuberculosis (Central Veterinary
Laboratory, Weybridge, Surrey, UK). In the second
set of experiments 1x106 cells-ml-1 alveolar macro-
phages were co-cultured with 4x106 cells.ml-1 auto-
logous lymphocytes (1:4 ratio) [23]. In the third set of
experiments, 1x106 cells.ml-1 alveolar macrophages
a d 4x106 cells.ml-1 autologous lymphocytes were co-
cultu ed with 20 µg.ml-1 of PPD. In a similar way.
5x106 cells.ml-1 peripheral blood mononuclear cells
were cultured with or without PPD (20 µg.ml-1) for 72 h.
Th  culture supernatants of all the cultures, were taken
after 72 h of incubation at 37°C and centrifuged at 400xg
for 10 min, and the cell-free supernatants were assayed
for procoagulant activity.
Assay for procoagulant activity (PCA)
Th  procoagulant activity of the cell-free superna-
tants of the lavage fluids and the spontaneous and PPD
stimulated culture supernatants of alveolar macrophages,
onocytes, alveolar macrophages co-cultured with auto-
logous lymphocytes, and peripheral blood mononuclear
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cells were measured. The PCA of the supernatants were
assessed using a standard one-stage clotting assay [24,
25]. Briefly, 100 µl of the supernatants were prewarmed
at 37°C for 3 min, together with 100 µl of 0.025 M cal-
cium chloride, in 76x9 mm glass tubes. Citrated nor-
mal human plasma, 100 µl, prewarmed to 37°C was then
added and the clotting time determined by the manual
tilt method. All supernatants were assayed in duplicate.
A value for the PCA was derived by comparison of the
clotting times with the coagulant activity of standard
rabbit thromboplastin (Sigma Chemical Co., St. Louis,
MO, USA). One hundred microlitres of standard was
assigned a value of 1,000 milliunits (mU) of PCA (10,000
mU-ml-1). The activity of the standard was also assayed
in duplicates and found to be linear on a log/log plot of
clotting time against units of PCA, over the range 0.1-1,000
mU. The PCA of the supernatants were expressed as
mU-ml-1 for cell-free supernatants of the BAL fluids. For
in vitro culture supernatants of alveolar macrophages,
monocytes and mononuclear cells the PCA is expressed
as mU-10-5 cells.
Statistical methods
The results are expressed as arithmetic mean±standard
error (SEM). Statistical analysis was performed using
Mann-Whitney U-test (nonparametic test).
RESULTS
All increases/decreases, reported below were found
to be not significant using the Mann-Whitney test, and
thus indicate trends or tendencies only. The percentage
fluid recovery, the total and differential cell count
analysis of the alveolar lavage fluids taken from the site
of the pulmonary lesion (RAS) and an unaffected site
(RNS) of active and inactive (cured) pulmonary tuber-
culosis patients revealed no difference at the fluid reco-
very and the cellular level (table 1). Five of the 7 active,
and 5 of the 9 inactive TB patients had no lymphocytic
alveolitis (<20% lymphocytes).
Fig. 1. - Precoagulant activity (PCA) of cell-free supernatants of
bronchoalveolar lavage fluids taken from the site of lesion (radiologi-
cally abnormal site (RAS)) and an unaffected site other than the infec-
ted lobe (radiologically normal site (RNS)) in a) patients with active
and b) inactive pulmonary tuberculosis, respectively. *: only one
sample (RAS) available; corresponding (RNS) sample not determined
• : RAS; o: RNS.
The cell-free supenatants of the active TB BALFig.: 1 shows that 3/7 of the active TB group had PCA
fluids taken from the site of lesion (RAS) showed anvalues <200 mU-ml-1 similar to the inactive TB group.
increase in the procoagulant activity (mean±SEM 130.2 No difference was observed in the PCA level between
±52.3 mU) when compared to the lavage fluids ta-RAS (130.2±52.3 mU) and RNS (86.1±44.1 mU) of
ken from RAS of inactive-TB patients (24.8±19.7 mU).active and inactive tuberculosis patients (fig. 1).
Table 1. - Percentage fluid recovery, total and differential cell counts of alveolar lavage fluids taken from the site of
tuberculous pulmonary lesion and an unaffected site
Group Site of lesion (RAS) Unaffected site (RNS)
% Fluid Total+ Differential counts % % Fluid Total+ Differential counts %
recovery cells recovery cells
Mac Lymph Neut Eos Mac Lymph Neut Eos
Active-TB * 64±8 22±7 77±3 17±3 4±1 2±1 69±6 15±4 72±3 20±2 5±1 2±1
Inactive-TB† 61±4 21±5 83±3 12±3 3±1 2±1 64±7 19±5 74±4 19±4 5±1 1±0
+: 106 cells-dl-1; *: RAS n=7 patients, and RNS n=5 patients;†: RAS n=9 patients, and RNS n=6 patients. Mac: macrophages;
Lymph: lymphocytes; Neut:neutrophils; Eos: eosinophils.
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Table 2. - Effect of purified protein derivative (PPD) of M. tuberculosis on the PCA producing potential of alveolar
macrophages and peripheral blood adherent (monocytes) and nonadherent (lymphocytes) mononuclear cells
Subjects
Alveolar macrophages
PCA in mU*
Peripheral blood
PCA in mU*†
Site of lesion (RAS)
AM AM
PPD
Unaffected site (RNS)
AM AM
PPD
Adherent Adherent Non-adherent
mononuclear mononuclear mononuclear
cells cells + PPD cells
Active-TB 15.8±6.3 32.1±22.6 21.8±20.8 32.7±31.8 15.9±12.9 12.1±9.2 8.2±3.8 
(n=5) (n=5) (n=5) (n=5) (n=6) (n=6) (n=6)
Inactive-TB 8.9±7.6 14.6±10.7 13.5±8.0 22.5±14.8 0.8±0.4 2.6±1.1 0.9±0.4
(n=6) (n=6) (n=6) (n=6) (n=8) (n=8) (n=8)
Normals ND ND ND ND 0.22±0.13
(n=7)
0.4±0.3 ND
(n=7)
Mean±SEM. Numbers in parentheses represent the actual number of subjects studied. ND: not determined; AM: alveolar
macrophages; PCA: procoagulant activity.*: PCA in mU or 105 alveolar macrophages (AM) or peripheral. blood adherent
(monocytes) cells;†: PCA in mU per 5x105 peripheral blood nonadherent (lymphocytes) cells. More than 95% of the nonad-
herent cell population were lymphocytes.
Fig. 2. - Effect of autologous lymphocytes and purified protein derivative (PPD) (20 µg-ml-1) on the PCA producing potential of alveolar
macrophages (AM). The PCA producing potential of alveolar macrophages taken from the site of lesion (RAS) and unaffected site (RNS) of: a)
3 active; and b) 6 inactive (cur d) pulmonary tuberculosis patients were studied independently and compared. For abbreviations see legend to fig-
ure •  • : RAS; o---o: RNS.
The procoagulant activity releasing potential of the
alveolar macrophages harvested from patients with ac-
tive or inactive tuberculosis was similar. Furthermore,
stimulation of alveolar macrophages with PPD showed
a moderate increase in the PCA of alveolar macrophages
taken from RAS and RNS of active-TB and inactive-
TB patients (table 2).
When the alveolar cells from patients with active
tuberculosis were co-cultured with autologous lympho-
cytes (1:4 ratio) an increase in the PCA was evident,
compared to the PCA released by the alveolar macro-
phages alone (fig. 2). An increased PCA response was
seen with the macrophages of RNS when compared
to RAS recruited macrophages of active-TB patients
(RAS 63.7±1.9; RNS 100±11.5). However, alveolar
macrophages of RAS and RNS of active-TB patients
co-cultured with autologous lymphocytes and PPD
showed a variable (enhanced or suppressed) PCA rel-
ease, compared to non-PPD stimulated cells (fig. 2a). In
inactive-TB patients, cultures of alveolar macrophages
with autologous lymphocytes, with or without stimula-
tion with PPD showed variable responses (fig. 2b).
T e PCA of the peripheral blood monocytes of active-
TB or inactive-TB patients was comparable to that of
the alveolar macrophages of either active or inactive
stage of tuberculosis (figs. 2 and 3).
The spontaneous and PPD-induced procoagulant acti-
vity of the peripheral blood adherent mononuclear cells
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was higher in cells derived from active-TB patients than
from the inactive-TB patients and normal individuals
(table 2). When the total mononuclear cells of active-
TB patients were stimulated with PPD, 5/7 patients sho-
wed an increase in their PCA production. This appears
similar to the responses in inactive-m and normals (fig.
3).
Discussion
Bronchoalveolar lavage fluids and lung alveolar
macrophages from humans have been shown to contain
procoagulant activities [25-29]. Furthermore, it has
been shown that the PCA of the lavage fluids are mem-
brane vesicles consisting exclusively of alveolar macro-
phage membrane material [25, 29, 30]. In the present
study, an increased procoagulant activity was seen in
the cell-free supematants of active-TB lavage fluids ta-
ken from the site of lesion (RAS) compared to the lav-
age fluids from inactive-TB patients. This increase was
not significant, however, and thus indicates a trend only.
The same is true for the other differences observed in
this study.
The increased procoagulant activity of the cell-free
supernatants of the lavage fluids may be due to the PCA
containing microvesicles that are released at the site of
lesion (RAS) by the alveolar macrophages and other cells,
such as fibroblasts [12], to promote coagulation.
Alveolar lavage fluids taken from RAS and RNS of
active-TB patients showed no difference in their PCA
level. This suggests that the alveolar macrophages
which are residing at the site of lesion (RAS) and at
the unaffected site (RNS) are equally sensitized to the
antigens of M. tuberculosis, and capable of releasing
PCA into the microenvironment of the alveolar space.
In contrast, lavage fluids taken from radiologically ab-
normal site of inactive-TB patients showed a low level
of PCA. This low level of PCA in the BAL, fluids of
inactive-TB patients may be due to an unresponsive
state of the alveolar macrophages, or to a low propor-
tion of M. tuberculosis sensitized macrophages, at the
sites of RAS and RNS.
Alveolar macrophages taken from the site of lesion
(RAS) and unaffected site (RNS) of both active-TB
and inactive-TB patients produced a low level of spon-
taneous and PPD-induced PCA in vitro. However,
alveolar macrophages co-cultured with autologous lym-
phocytes (1:4 ratio) showed a variable (increased or
decreased) spontaneous and PPD-induced PCA produc-
tion. This reveals that the PCA-releasing potential of
alveolar macrophages is influenced by lymphocytes,
and that lymphocyte co-operation seems necessary for
the increased PCA production. It has been shown that
T-lymphocytes [23] and T-lymphocyte factors [31] are
important for the increased production of PCA by the
m ocytes and macrophages. Further, the monocyte
procoagulant-inducing factor (MPIF) has been shown
to be a T-helper cell derived cytokine, that may play
a collaborative role in the expression of cell-mediated
immune responses [32].
Th PCA releasing potential of the peripheral blood
monocytes, monocytes co-cultured with lymphocytes as
mononuclear cells with or without stimulation with
PPD, was also comparable to that of the alveolar macro-
phages of the active-TB and inactive-TB patients. Peri-
pheral blood monocytes and mononuclear cells of 
ormal subjects produced a low level of PCA. Mono-
nuclear blood cells with or without stimulation with
   PPD showed a higher PCA production in active-TB
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patients than in inactive-TB patients and normal sub-
jects. This suggests that the peripheral blood monocytes
and the lymphocytes of active tuberculosis patients are
sensitized to PPD antigen. The monocytes and lym-
phocytes of inactive-TB patients and normal subjects
are in an unresponsive state or less sensitized to the stim-
ulating antigen.
The present study suggests that the alveolar macro-
phages taken from the site of lesion (RAS) and the
unaffected site (RN) of the active-TB patients are equ-
ally competent in their PCA producing potential. In-
creased production of procoagulant activity by the
alveolar macrophages of active-TB patients during
inflammation may result in fibrin formation, a cell-
mediated immune reaction. The fibrin deposition in
the alveolar space and interstitial tissue may lead to fur-
ther lung injury.
1.
2.
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